- increased fasting circulating glucose level / IMPC
- decreased total body fat amount / IMPC
- increased lean body mass / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- persistence of hyaloid vascular system / IMPC
- abnormal optic disk morphology / IMPC
- abnormal auditory brainstem response / IMPC
- increased circulating cholesterol level / IMPC
- increased mean corpuscular volume / IMPC
C57BL/6NTac-Cidectm1a(EUCOMM)Wtsi/Cnrm
Status | Available to order |
EMMA ID | EM:04019 |
International strain name | C57BL/6NTac-Cidectm1a(EUCOMM)Wtsi/Cnrm |
Alternative name | EPD0116_3_D06 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cidectm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Cidec |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | CNR, Consiglio Nazionale delle Ricerche |
Provider affiliation | EMMA-Monterotondo Campus International Development, CNR, Consiglio Nazionale delle Ricerche |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0116_3_D06. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- CIDEC-related familial partial lipodystrophy / Orphanet_435651
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- decreased white adipose tissue amount / MGI
- no abnormal phenotype detected / MGI
- decreased susceptibility to hepatic steatosis / MGI
- decreased circulating triglyceride level / MGI
- decreased circulating free fatty acid level / MGI
- increased insulin sensitivity / MGI
- abnormal white adipose tissue morphology / MGI
- abnormal brown adipose tissue morphology / MGI
- decreased susceptibility to age related obesity / MGI
- decreased circulating ketone body level / MGI
- increased energy expenditure / MGI
- increased oxygen consumption / MGI
- improved glucose tolerance / MGI
- abnormal fat pad morphology / MGI
- abnormal gonadal fat pad morphology / MGI
- vision/eye phenotype / MGI
- increased body temperature / MGI
- decreased circulating glucose level / MGI
- decreased susceptibility to diet-induced obesity / MGI
- decreased circulating leptin level / MGI
- enhanced lipolysis / MGI
- decreased subcutaneous adipose tissue amount / MGI
- abnormal fat cell morphology / MGI
- decreased gonadal fat pad weight / MGI
- decreased inguinal fat pad weight / MGI
- decreased mesenteric fat pad weight / MGI
- decreased retroperitoneal fat pad weight / MGI
- abnormal blood homeostasis / MGI
- decreased total body fat amount / MGI
- increased respiratory quotient / MGI
- integument phenotype / MGI
- impaired adaptive thermogenesis / MGI
- increased food intake / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).